-
Mashup Score: 24Clinical Trial of New Targeted Agent a Boon for Patient With AML | Dana-Farber Cancer Institute - 23 day(s) ago
Published: February 13, 2024Written by: Rob LevyWhen Youling Sun was diagnosed in Shanghai, China, with acute myeloid leukemia (AML) in 2018, he called his son, Conghao, in Boston, for advice. His son’s message was unequivocal: Come to Boston for your treatment. Today, Sun, a retired office worker from Shanghai, has multiple reasons to be thankful … Read more
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 24Clinical Trial of New Targeted Agent a Boon for Patient With AML | Dana-Farber Cancer Institute - 3 month(s) ago
Published: February 13, 2024Written by: Rob LevyWhen Youling Sun was diagnosed in Shanghai, China, with acute myeloid leukemia (AML) in 2018, he called his son, Conghao, in Boston, for advice. His son’s message was unequivocal: Come to Boston for your treatment. Today, Sun, a retired office worker from Shanghai, has multiple reasons to be thankful … Read more
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet-
When Youling Sun was diagnosed in #Shanghai with acute myeloid leukemia in 2018, he called his son for advice. His son’s message was unequivocal: Come to Boston for your treatment. #AML Today, Sun has multiple reasons to be thankful he took that advice. https://t.co/sq6GykiUvL https://t.co/LWgWAksfHl
-
When Youling Sun was diagnosed in #Shanghai with acute myeloid leukemia in 2018, he called his son for advice. His son’s message was unequivocal: Come to Boston for your treatment. #AML Today, Sun has multiple reasons to be thankful he took that advice. https://t.co/sq6GykiUvL https://t.co/LWgWAksfHl